{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:33:47Z","timestamp":1771562027137,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1124\/jpet.111.179671","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T03:29:57Z","timestamp":1301542197000},"page":"214-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol"],"prefix":"10.1016","volume":"338","author":[{"given":"Karsten K.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarke","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus P.","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Povl","family":"Krogsgaard-Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Steve","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.179671_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0197-0186(95)00158-1","article-title":"GABA transporter heterogeneity: pharmacology and cellular localization","volume":"29","author":"Borden","year":"1996","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.111.179671_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.1471-4159.1995.64030977.x","article-title":"Cloning and expression of a betaine\/GABA transporter from human brain","volume":"64","author":"Borden","year":"1995","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.179671_bib3","doi-asserted-by":"crossref","first-page":"15230","DOI":"10.1073\/pnas.0604304103","article-title":"GABAA receptor \u03b14 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol","volume":"103","author":"Chandra","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.179671_bib4","first-page":"127","article-title":"Antinociceptive and anticonvulsive effect of THIP, a pure GABA agonist","volume":"34","author":"Christensen","year":"1982","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1124\/jpet.111.179671_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bmc.2004.10.029","article-title":"Selective inhibitors of GABA uptake: synthesis and molecular pharmacology of 4-N-methylamino-4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol analogues","volume":"13","author":"Clausen","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.111.179671_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9861(19980622)396:1<51::AID-CNE5>3.0.CO;2-H","article-title":"Neuronal and glial localization of GAT-1, a high-affinity gamma-aminobutyric acid plasma membrane transporter, in human cerebral cortex: with a note on its distribution in monkey cortex","volume":"396","author":"Conti","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.111.179671_bib7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1096-9861(19990705)409:3<482::AID-CNE11>3.0.CO;2-O","article-title":"Neuronal, glial, and epithelial localization of \u03b3-aminobutyric acid transporter 2, a high-affinity \u03b3-aminobutyric acid plasma membrane transporter, in the cerebral cortex and neighboring structures","volume":"409","author":"Conti","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1124\/jpet.111.179671_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2007.01.017","article-title":"Plasma and CNS concentrations of Gaboxadol in rats following subcutaneous administration","volume":"562","author":"Cremers","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.111.179671_bib10","series-title":"Probit Analysis","author":"Finney","year":"1971"},{"key":"10.1124\/jpet.111.179671_bib11","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.111.179671_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(97)01044-3","article-title":"Differential effects of nipecotic acid and 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol on extracellular \u03b3-aminobutyrate levels in rat thalamus","volume":"331","author":"Juh\u00e1sz","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2004.06.040","article-title":"GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic","volume":"68","author":"Krogsgaard-Larsen","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0021-9258(18)53968-5","article-title":"Molecular characterization of four pharmacologically distinct gamma-aminobutyric acid transporters in mouse brain [corrected]","volume":"268","author":"Liu","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.179671_bib15","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"LOEWE","year":"1953","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 1","key":"10.1124\/jpet.111.179671_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1471-4159.2009.05982.x","article-title":"Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs","volume":"109","author":"Madsen","year":"2009","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.179671_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pharmthera.2009.11.007","article-title":"Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs","volume":"125","author":"Madsen","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.111.179671_bib18","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1523\/JNEUROSCI.16-19-06255.1996","article-title":"GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex","volume":"16","author":"Minelli","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.179671_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(91)90438-V","article-title":"Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor","volume":"196","author":"Nielsen","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib20","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1152\/jn.2002.87.5.2624","article-title":"Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells","volume":"87","author":"Nusser","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1124\/jpet.111.179671_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1022397704922","article-title":"Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission","volume":"28","author":"Schousboe","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.111.179671_bib22","series-title":"Encyclopedia of Basic Epilepsy Research","first-page":"397","article-title":"Glial modulation of excitability via glutamate and GABA transporters","author":"Schousboe","year":"2009"},{"key":"10.1124\/jpet.111.179671_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(03)00528-2","article-title":"A tale of timing and transport","volume":"39","author":"Stell","year":"2003","journal-title":"Neuron"},{"key":"10.1124\/jpet.111.179671_bib24","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at \u03b4-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of \u03b32","volume":"316","author":"St\u00f3rustovu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179671_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(92)90193-F","article-title":"Statistical analysis of drug combinations for synergism","volume":"49","author":"Tallarida","year":"1992","journal-title":"Pain"},{"key":"10.1124\/jpet.111.179671_bib26","doi-asserted-by":"crossref","first-page":"PL417","DOI":"10.1016\/S0024-3205(97)01030-8","article-title":"Efficient designs for studying synergistic drug combinations","volume":"61","author":"Tallarida","year":"1997","journal-title":"Life Sci"},{"key":"10.1124\/jpet.111.179671_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol\u2014a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib28","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.1523\/JNEUROSCI.23-33-10650.2003","article-title":"Perisynaptic localization of \u03b4 subunit-containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus","volume":"23","author":"Wei","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.179671_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(93)90238-D","article-title":"Anticonvulsant activity of the gamma-aminobutyric acid uptake inhibitor N-4,4-diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol","volume":"236","author":"White","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179671_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.102.034819","volume":"302","author":"White","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179671_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/jpet.104.068825","article-title":"First demonstration of a functional role for central nervous system betaine\/\u03b3-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2","volume":"312","author":"White","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179671_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:NEUR.0000030698.66675.90","article-title":"A light and electron microscopic study of betaine\/GABA transporter distribution in the monkey cerebral neocortex and hippocampus","volume":"33","author":"Zhu","year":"2004","journal-title":"J Neurocytol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.179671","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:31:58Z","timestamp":1740018718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524464410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022356524464410"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.179671","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.179671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}